Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma TOKYO, CAMBRIDGE (UK), August 10, 2018 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., “Astellas”) and Quethera Limited (CEO: Peter Widdowson, Ph.D., “Quethera”) today announced that Astellas has acquired Quethera, a gene therapy company headquartered […]
read moreBanana plantations in Australia, south-east Asia, Africa and the Middle East have been ravaged by the ‘fusarium wilt’ fungus – and Latin America could be next. Photograph: Jacek Sopotnicki/REX/Shutterstock British firm Tropic Bioscience races to produce bananas resistant to fungus sweeping global plantations https://www.theguardian.com/global-development/2018/jun/18/scientists-scramble-to-stop-bananas-being-killed-off
read moreCAMBRIDGE, UK, 11 June 2018—Silicon Microgravity (SMG), a spin-out from both BP and the University of Cambridge, has raised $7 million from IP Group, Parkwalk, BP Ventures and Cambridge Enterprise. Silicon Microgravity Limited is a privately held company focused on developing and applying innovative technology primarily to improve surveillance, appraisal and production of oil and […]
read more